Enlaza Therapeutics, Inc.

Form D Filings

Location
La Jolla, CA
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001852950
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
9/10/2025 Equity $15,000,000 $15,000,000 $15,000,000 $0 8/29/2025 9/10/2025 D 000123191925000186
8/9/2024 Equity $84,000,000 $84,000,000 $110,000,000 $26,000,000 4/5/2024 8/9/2024 D 000185295024000001
11/22/2022 Equity $31,280,607 $35,299,237 $61,330,607 $26,031,370 3/12/2021 11/22/2022 D/A 000185295022000003
10/13/2022 Equity $0 $0 Indefinite Indefinite 9/30/2022 10/12/2022 D 000185295022000001
10/13/2022 Equity $0 $0 $311,977 $311,977 10/4/2022 10/12/2022 D 000185295022000002
8/13/2021 Equity $0 $0 Indefinite Indefinite 7/30/2021 8/13/2021 D 000185295021000003
6/28/2021 Equity $0 $0 Indefinite Indefinite 6/10/2021 6/28/2021 D 000185295021000002
3/25/2021 Equity $4,018,630 $4,018,630 $21,273,287 $17,254,657 3/12/2021 3/22/2021 D 000185295021000001